Search research articles
Contact Us
Filters
Showing results (831-840 of 903) with videos related to
Page
of 91
Sort By:
Neurology
|
June 11, 2020
Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic
Salvatore C Rametta, Sara E Fridinger, Alexander K Gonzalez, et al.
The Journal of Clinical Investigation
|
July 3, 2025
Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions
Matthew S Karafin, Abby L Grier, Ross M Fasano, et al.
The Prostate
|
January 22, 2019
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
Daniel P Petrylak, Philip Kantoff, Nicholas J Vogelzang, et al.
British Journal of Cancer
|
October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
I Brana, R Berger, T Golan, et al.
Msphere
|
May 1, 2020
Under-the-Radar Dengue Virus Infections in Natural Populations of Aedes aegypti Mosquitoes
Sean M Boyles, Carla N Mavian, Esteban Finol, et al.
Urology
|
June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance
Vishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
JAMA
|
March 18, 2004
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Shahrokh F Shariat, Michael J Zelefsky, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 15, 2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
John A Lednicky, Michael Lauzardo, Z Hugh Fan, et al.
The Journal of Urology
|
March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
Yaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
Orphanet Journal of Rare Diseases
|
May 6, 2021
Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations
Kirk A J Stephenson, Julia Zhu, Niamh Wynne, et al.
Page
of 91
Search research articles
Search
Showing results (831-840 of 903) with videos related to
Sort By:
Page
of 91
Neurology
|
June 11, 2020
Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic
Salvatore C Rametta, Sara E Fridinger, Alexander K Gonzalez, et al.
The Journal of Clinical Investigation
|
July 3, 2025
Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions
Matthew S Karafin, Abby L Grier, Ross M Fasano, et al.
The Prostate
|
January 22, 2019
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
Daniel P Petrylak, Philip Kantoff, Nicholas J Vogelzang, et al.
British Journal of Cancer
|
October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
I Brana, R Berger, T Golan, et al.
Msphere
|
May 1, 2020
Under-the-Radar Dengue Virus Infections in Natural Populations of Aedes aegypti Mosquitoes
Sean M Boyles, Carla N Mavian, Esteban Finol, et al.
Urology
|
June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance
Vishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
JAMA
|
March 18, 2004
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Shahrokh F Shariat, Michael J Zelefsky, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 15, 2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
John A Lednicky, Michael Lauzardo, Z Hugh Fan, et al.
The Journal of Urology
|
March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
Yaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
Orphanet Journal of Rare Diseases
|
May 6, 2021
Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations
Kirk A J Stephenson, Julia Zhu, Niamh Wynne, et al.
Page
of 91